Frederic Marguerre
Amministratore Delegato presso Octapharma Plasma GmbH
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Wolfgang Marguerre | M | 83 |
Octapharma AG
 Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
| Nicholas Jacobson | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
| Daniel Wyder | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
| Marlis Kueng | F | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
| Marc Maltas | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
| Hubert Franzaring | M | - |
Octapharma Plasma GmbH
 Octapharma Plasma GmbH Pharmaceuticals: MajorHealth Technology Part of Octapharma AG, Octapharma Plasma GmbH is a German company that manufactures and distributes finished plasma products. The company is based in Langenfeld, Germany. The CEOs are Hubert Franzaring, Frederic Marguerre. The company was founded in 2002. | - |
| Roger Mächler | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
| Matt Riordan | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Svizzera | 7 | 87.50% |
| Germania | 1 | 12.50% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Frederic Marguerre
- Contatti personali
